Podcasts about aprn cnp

How does team-based care work? What are the advantages of team-based care? What is team-based care in health care? What does a nurse practitioner do? Kevin Hopkins, MD, and Amanda Mitch, MSN, APRN-CNP, from the Cleveland Clinic Primary Care Institute discuss the importance of physician-led care, teamwork, and how mutual respect builds trust and improves patient outcomes. American Medical Association CXO Todd Unger hosts.

About my Guest:  Erin Files is a board certified family nurse practitioner specializing in functional, hormonal, and aesthetic medicine.  She has been practicing functional medicine for 12 years and has owned Encompass Wellness and Aesthetics for almost ten years.  She is a member of American Academy of Anti-Aging Medicine, The Institute of Functional Medicine, and the American Academy of Facial Aesthetics.  Her practice focuses on getting to the root cause of health issues and working to make you look your best, inside and out.     Erin Files: Instagram Website Summary: Dr. Cassie Smith and Erin Files discuss the challenges of traditional medicine and the importance of functional medicine in treating patients holistically. They emphasize the need to address the root causes of diseases and focus on lifestyle changes rather than relying solely on medications. The conversation highlights the role of education in empowering patients to take control of their health and make informed decisions. They also discuss the limitations of insurance companies in supporting functional medicine practices and the need for a shift towards a more patient-centered approach. In this conversation, Cassie and Erin discuss the importance of self-acceptance and self-talk, as well as the role of functional medicine in treating complex health conditions. They emphasize the need to meet patients where they are and provide individualized care. They also address common misconceptions about hormones and the use of fillers in individuals with autoimmune diseases. Erin introduces a new procedure called Beautifill, which uses the patient's own fat for facial rejuvenation. The conversation concludes with three health tips: the benefits of broccoli, the importance of exercise, and the impact of diet on overall health. Time Stamps:  00:00 Introduction and Overview 01:49 Erin Files' Journey into Functional Medicine 05:06 The Difference Between Functional and Traditional Medicine 09:22 The Importance of Gut Health and Detoxification 13:31 The Role of Education in Functional Medicine 18:41 The Limitations of Insurance Companies in Supporting Functional Medicine 25:01 The Challenges of Traditional Medicine 28:50 The Power of Self-Acceptance and Positive Self-Talk 30:13 The Role of Functional Medicine in Individualized Care 35:51 Dispelling Misconceptions about Hormones and Fillers 43:48 Introducing Butafil: A Natural and Long-Lasting Facial Rejuvenation Procedure 50:13 The Benefits of Broccoli for Detoxification and Health 51:12 The Importance of Exercise for Muscle Mass and Overall Health 53:02 The Impact of Diet on Chronic Disease Prevention Connect with Modern Endocrine: Check out the website Follow Cassie on Instagram Follow Cassie on Facebook Follow Cassie on YouTube Follow Cassie on TikTok Sign up for Modern Endocrine's newsletter Disclaimer 

The James provides a comprehensive survivorship program for patients and their families. “People are living longer with cancer and how do we make sure they have the best quality of life during their treatment and the years beyond,” said Denise Schimming, APRN-CNP, a certified nurse practitioner and survivorship specialist. Schimming and Julie DeBord, MSW, LISW-S, manager of JamesCare for Life, discussed the history, growth, the numerous and growing number of programs they offer and how they connect with patients and their families. “JamesCare for Life has been around for more than 20 years,” DeBord said. “We started with 10 programs and now we average more than 30 programs a month and we're continually looking at how can we meet the needs of our cancer patients and their families.” Some of the many programs JamesCare for Life offers include music and art therapy, nutrition classes and healthy cooking demonstrations, physical therapy, individual and group sessions from mental-health professionals, and presentations by James experts on a wide range of cancer-related topics, such as lymphedema. JamesCare for Life also provides equine therapy for families and the Garden of Hope is a large farm that provides patients and caregivers the opportunity to harvest and take home a wide variety of vegetables and herbs. “Cancer can be isolating and scary and we have educational classes to help with coping during times of uncertainty to manage stress, mindfulness programs for stress reduction and support groups and one-on-one care support,” DeBord said. Schimming and her team connect with patients while they undergo treatment, while DeBord and her JamesCare for Life team offer free programs for patients and their caregivers after treatment. Schimming and DeBord work together to meet the needs of patients and create new programs. An example is the recent addition of two certified child-life specialists. “We heard from patients that they didn't know how to tell their children and their grandchildren about their cancer,” Schimming said. “We hired two certified child-life specialists, one for inpatients and one for outpatients. They're experts in helping families cope with medical illness and we created a special playroom [in the James] for these interventions.”

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA/AAPA information, and to apply for credit, please visit us at PeerView.com/USZ865. NCPD/ILNA/AAPA credit will be available until May 8, 2025.Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer: Best Practices for Adverse Event Management and Patient Education In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and The Chrysalis Initiative. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA/AAPA information, and to apply for credit, please visit us at PeerView.com/USZ865. NCPD/ILNA/AAPA credit will be available until May 8, 2025.Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer: Best Practices for Adverse Event Management and Patient Education In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and The Chrysalis Initiative. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA/AAPA information, and to apply for credit, please visit us at PeerView.com/USZ865. NCPD/ILNA/AAPA credit will be available until May 8, 2025.Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer: Best Practices for Adverse Event Management and Patient Education In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and The Chrysalis Initiative. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA/AAPA information, and to apply for credit, please visit us at PeerView.com/USZ865. NCPD/ILNA/AAPA credit will be available until May 8, 2025.Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer: Best Practices for Adverse Event Management and Patient Education In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and The Chrysalis Initiative. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA/AAPA information, and to apply for credit, please visit us at PeerView.com/USZ865. NCPD/ILNA/AAPA credit will be available until May 8, 2025.Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer: Best Practices for Adverse Event Management and Patient Education In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and The Chrysalis Initiative. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA/AAPA information, and to apply for credit, please visit us at PeerView.com/USZ865. NCPD/ILNA/AAPA credit will be available until May 8, 2025.Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer: Best Practices for Adverse Event Management and Patient Education In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and The Chrysalis Initiative. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

Join me for this week's episode where I interview Andrea Cooper, MS, APRN-CNM, APRN-CNP. Andrea is a life coach for women and the founder of Coaching with Coop, LLC. She has cared for women as a midwife for over a decade, is a former board member for the Ohio Affiliate of the American College of Nurse-Midwives. In addition to coaching, she practices clinically and coordinates research on nurses' mental health. Tune in to hear... Why the PhD program wasn't right for her at the time Why coaching felt like the right fit What it means to honor autonomy for women (and why it matters) Contact Information for Andrea: Email: acoopercnm@gmail.com Instagram: @CoachingwithCoop

“First, you want to refer patients to an eye care provider prior to initiating therapy, and I think communication at this point is really important. You need to tell the eye care provider why they're being referred, what treatment they're getting, the most common ocular toxicities, and also what needs to be done at every visit. They need to do a visual acuity; they need to do a slit-lamp eye exam. And these eye care providers need to know that ahead of time, so they're doing everything at that visit,” Courtney Arn, APRN-CNP, nurse practitioner at the Ohio State University James Cancer Hospital in Columbus, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about ocular toxicities and their management in cancer care. The advertising messages in this episode are paid for by Dartmouth Hitchcock Cancer Center. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Episode Notes NCPD contact hours are not available for this episode. Oncology Nursing Podcast Cancer Symptom Management Basics series: Episode 244: Cancer Symptom Management Basics: Cardiovascular Complications Episode 250: Cancer Symptom Management Basics: Dermatologic Complications Episode 256: Cancer Symptom Management Basics: Hematologic Complications Episode 269: Cancer Symptom Management Basics: Gastrointestinal Complications Episode 278: Cancer Symptom Management Basics: Hepatic Complications Episode 290: Cancer Symptom Management Basics: Peripheral Neuropathy ONS Voice articles: Oncology Drug Reference Sheet: Mirvetuximab Soravtansine-Gynx Oncology Drug Reference Sheet: Tisotumab Vedotin-Tftv Oncology Drug Reference Sheet: Belantamab Mafodotin-Blmf ONS courses: ONS Cancer Basics™ Essentials in Advanced Practice Symptom Management Treatment and Symptom Management—Oncology RN Symptom Management—Oncology APN ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Manual for the Oncology Advanced Practice Nurse (fourth edition) Clinical Journal of Oncology Nursing articles: Transfusion Reactions: A Case Study of an Ocular Adverse Event During Autologous Transplantation Ocular Graft-Versus-Host Disease After Allogeneic Transplantation Enfortumab Vedotin: Nursing Perspectives on the Management of Adverse Events in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Oncology Nursing Forum article: Ocular Toxicity of Tyrosine Kinase Inhibitors To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “The most common ocular toxicities that we see with cancer treatments currently are vision impairment, which can include decreased visual acuity or blurred vision. We also see keratopathy or keratitis, very common to have dry eyes, photophobia, eye pain. Sometimes patients can develop cataracts, conjunctivitis, or even blepharitis, which is inflammation of the eyelid.” TS 2:27 “Fortunately, most of the ocular toxicities that develop when being treated with these treatments are short term, and so most of them are reversible. And they actually resolve relatively quickly after stopping treatment that's causing the ocular toxicity. So usually within one to two months, the ocular toxicities have significantly improved or resolved.” TS 4:55 “Sometimes patients come in and you're asking them, ‘Are you having any symptoms, or do you have any blurred vision?' And they'll say, you know, ‘I haven't been able to see my computer as well,' or ‘I've noticed when driving, I can't read the road sign.' And what I really hear often is watching TV, they can't see the scores of sports games at the bottom of the screen.” TS 7:43 “The nurses are very important in this process from the beginning of doing the patient education prior to them starting therapy, helping with the referral process to getting them in, making sure the patients have their eye drops, making sure they know how to use their eye drops, making sure they're aware of the signs and symptoms to be calling and reporting, and then also identifying at their visits, too, if they're having any new symptoms. So they definitely play a heavy, heavy role in this process.” TS 14:22

In this week's episode of the Fierce Factor Podcast, I am thrilled to continue unraveling the compelling journey of Jenny Guthrie, a remarkable member of our POP Leadership Academy and owner of Glow Medical Aesthetics. In this episode, we delve even deeper into Jenny's dynamic experience, peeling back layers to expose the unfiltered truths of our industry. Join us as we candidly discuss the keys to success for female entrepreneurs in the realm of aesthetics and in life. Part two of our interview explores the intricacies of team building, addressing questions about autonomy, trust, and the challenges surrounding personnel transitions. Jenny candidly shares insights into true thought leadership, the deceptive nature of social media optics, and the art of standing out in a world obsessed with chasing algorithms. Jenny unveils her proprietary methodology, offering a glimpse into its transformative impact on the Glow brand. She reflects on her personal journey, delving into the adversities and challenges that have shaped her, and contemplates their lasting impact on her future. Throughout this episode, Jenny imparts invaluable wisdom derived from her realization that control is an illusion. Instead, she advocates for the courage to embrace the unknown and accept any outcome that comes your way. Enjoy this incredible part 2 episode! Xo, Kaeli Follow Jenny on Instagram Watch the interview on YouTube Book a Strategy Call with Team KLC Subscribe to our Weekly Newsletter, The Blueprint KLC Consulting Website Kaeli on Instagram Kaeli on LinkedIn

Welcome back to episode 203 of the Fierce Factor podcast. This week, we dive into the first part of an enlightening conversation with Jenny Guthrie, the visionary founder and leader of Glow Medical Aesthetics. With over 15 years of experience as a Nurse Practitioner, Jenny has not only injected patients in the Tulsa and Enid areas but has also served as an Allergan Medical Institute Trainer for 2 years, imparting her knowledge to the industry's best minds. She's the mastermind behind Glow's proprietary Tectonic methodology, crafting personalized, results-driven treatment plans. Glow, under Jenny's leadership, stands in the top 3% of Allergan accounts nationwide, recognized as one of the top 10 Medical Aesthetic practices in Oklahoma. In this episode, Kaeli delves into Jenny's journey, from her leap into entrepreneurship to the challenges of staying viable in business. Explore the common hurdles entrepreneurs face in their growth journey, from financial struggles evolving into personnel challenges, and eventually transforming into issues of thought leadership. In a candid discussion, Jenny shares her experiences navigating through personal and professional storms, including a reference to an employment experience she fondly refers to as "the titanic" during a challenging personal divorce. Discover Jenny's bold declaration to take control of her life in a unique way and the wisdom she imparts about courageously stepping into the unknown. As she emphasizes, there's no absolute control, only the courage to face uncertainties and embrace any outcome. Tune in for the inspiring first part of this conversation with the bold, beautiful, and brilliant Jenny Guthrie. Xo, Kaeli. Follow Jenny on Instagram Watch the interview on YouTube Book a Strategy Call with Team KLC Subscribe to our Weekly Newsletter, The Blueprint KLC Consulting Website Kaeli on Instagram Kaeli on LinkedIn

Pediatrician Dr. Paul Bunch consults Kelly Harris, APRN-CNP and Beth Moeves, MSN, FNP-BC on acne.  Episode recorded on December 6, 2023. CME & MOC Part 2 We are proud to offer CME and MOC Part 2 from Cincinnati Children's.  Credit is free and registration is required.  Please click here to claim CME credit via the post-test under "Launch Activity." Resources discussed in this episode: Community Practice Support Tools

“I think oftentimes people think this is just a radiology procedure that is rather benign. That's really the role of the oncology nurse, just to be [an educator], support, emotional support, and a coach,” Lisa Parks, MS, APRN-CNP, ANP-BC, nurse practitioner in hepatobiliary surgery at The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center in Columbus, Ohio, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about what oncology nurses should know about transarterial chemoembolization administration and their role surrounding that procedure. This episode is part of a series about non-IV chemotherapy administration; the others are linked below.  You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.   Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD), which may be applied to the oncology nursing practice or treatment ILNA categories, by listening to the full recording and completing an evaluation at myoutcomes.ons.org by November 10, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: The learner will report an increase in knowledge related to transarterial chemoembolization.   Episode Notes  Complete this evaluation for free NCPDComplete this evaluation for free NCPD.  Oncology Nursing Podcast episodes about non-IV chemotherapy administration:  Episode 271: Intraventricular and Intrathecal Administration: The Oncology Nurse's Role  Episode 265: Intravesical Administration: The Oncology Nurse's Role  Episode 252: Intraperitoneal Administration: The Oncology Nurse's Role  Oncology Nursing Forum articles:  Symptom Distress in Patients With Hepatocellular Carcinoma Toward the End of Life  Living With Hepatocellular Carcinoma Near the End of Life: Family Caregivers' Perspectives  ONS Chapters  To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From Today's Episode  “So, TACE was commonly used to treat liver metastatic cancers, primarily metastatic colon cancer, until research showed that some of these cancers were not responding to TACE. Therefore, it is no longer really used in metastatic colon cancer. TACE is used in hepatocellular cancer. It also was used more than 10 years ago to treat metastatic neuroendocrine cancers. But recent research has showed that neuroendocrine cancers respond to this embolization without the use of chemotherapy. By eliminating chemotherapy, we also eliminate the potential for side effects.” TS 3:29  “TACE, or TAE, is usually completed more than once in the course of a patient's treatment. Depending on the tumor burden of the liver, the procedure can be segmentally completed on a liver lobe, or you can do the procedure on the right lobe and then follow-up treatment in about six weeks in the left lobe.” TS 5:45  “This is something that isn't even really taught in medical school. So it's really important to understand that even though this is a postprocedural side effect, there are certain things that you have to be aware of. So, the most common side effect that you will see is right upper-quadrant pain, and this is very common. And if the left side of the liver has received the therapy, this pain can radiate to the epigastric area and the patient will describe it as chest pain. And when you have the patient point to that area where he's having pain, it's often epigastric and it's just a referred pain, it's not cardiac pain, typically. You can get a EKG and troponin, but those are almost always negative and it's just really part of this embolization syndrome.” TS 14:30  “As far as what the oncology nurse needs to really be aware of pre-TACE or pre-TAE, I just want to emphasize the importance of patient education. The patient and their family need to understand again, it's not a surgery, it's a radiology procedure, and that the patient is going to have abdominal pain and nausea and vomiting that will last for several weeks and that is why they are not kept in the hospital for three weeks until these symptoms dissipate. Oftentimes these symptoms will be present until they get reimaged at the medical oncologist and then it's time for them to come back and maybe get another phase of their procedure that they are supposed to have as part of their treatment plan.” TS 17:44  “I do want to let you know, though, that patients that have a significant spike of their transaminases over 1,000, those patients are of great concern of going into liver failure. So, the nurses need to let the patient know that they will be monitored and kept in the hospital until we start to see a downtrend in those transaminases before they will be discharged.” TS 19:48  “As an oncology nurse and medical oncology, [it's] education, education, education. Also being able to triage these patients on the phone, talking them through how to keep themselves hydrated. . . . So I just think it's really a coaching job of the oncology nurse. A lot of reassurance, a lot of suggestions on how to get through this very uncomfortable difficult procedure.” TS 21:16  “I want it to be clear that if you're doing local regional therapy, TACE or TAE, this is considered a palliative procedure. You are not going to get a cure with this treatment. In this situation, neuroendocrine carcinoma, it's already metastatic if you're treating the liver. And with hepatocellular, again, it's still palliative because you're not doing a surgical resection on this patient. And every TACE experience for every patient, I've had patients that've and I've had six of these procedures, every experience they get is different.” TS 28:11  “When the patient comes back to our floor after having the treatment, it's just very important for those nurses to know the ‘abnormal normal,' to know that some of the things that they're seeing, the hypertension, the severe pain, the severe nausea, is actually normal and the provider will work with them to try to come up with a regimen that will make the patient as comfortable as possible.” TS 33:22

“I think that as oncology nurses, we need to keep ourselves really educated and up to date with these new therapies, because I honestly feel like we still haven't really seen the long-term effects of this treatment,” ONS member Lisa Parks, MS, APRN-CNP, ANP-BC, nurse practitioner in hepatobiliary surgery at The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center in Columbus, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about recognizing hepatic complications and understanding the basics of its symptom management strategies. This episode is part of a series on cancer symptom management basics; the others are linked below.   You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.   Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0  Earn 0.5 NCPD contact hours of nursing continuing professional development (NCPD), which may be applied to the disease-related biology, treatment, or symptom management, palliative care, supportive care ILNA categories, by listening to the full recording and completing an evaluation at myoutcomes.ons.org by September 22, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.22, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: The learner will report an increase in knowledge in cancer symptom management basics and hepatic complications.   Episode Notes  Complete this evaluation for free NCPD.   Oncology Nursing Podcast:  Episode 269: Cancer Symptom Management Basics: Gastrointestinal Complications  Episode 256: Cancer Symptom Management Basics: Hematologic Complications  Episode 250: Cancer Symptom Management Basics: Dermatologic Complications   Episode 244: Cancer Symptom Management Basics: Cardiovascular Complications  ONS Voice article: To Prevent Hepatotoxicity, Monitor Liver Function During Cancer Treatment  Clinical Journal of Oncology Nursing articles:   Checkpoint Inhibitors: Common Immune-Related Adverse Events and Their Management  Identification and Management: Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Related to Hematopoietic Stem Cell Transplantation  Use of Hepatic Artery Infusion Pumps in the Treatment of Hepatic Metastases  ONS courses:  ONS/ONCC Chemotherapy Immunotherapy Certificate Course  ONS/ONCC Radiation Therapy Certificate Course  ONS books:  Cancer Basics (third edition)https://www.ons.org/books/cancer-basics-third-edition  Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition)  Manual for Radiation Oncology Nursing Practice and Education (fifth edition)  Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition)   American Gastroenterological Association  American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy    To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org    Highlights From Today's Episode  “There is something called chemotherapy-induced liver injury. What the chemotherapy does is it has a direct hepatotoxic effect on the hepatocytes themselves. If you have preexisting liver disease such as cirrhosis, it can lead to very severe hepatotoxicity because the function of the liver is already compromised by the damage previously done to it.” TS 3:47  “The American Gastroenterological Association published guidelines on the management of HBV reactivation for patients during immunosuppressive treatment, and they basically do recommend any patients with a hep B virus that they receive antiviral prophylaxis to prevent this reactivation from occurring. Also in 2008, the CDC recommended universal HBV screening for all patients before administering chemotherapy. This one you see most commonly in patients who receive chemotherapy for a hematological cancer following hemopoietic stem cell transplantation.” TS 14:19  “One of the most common things that I've encountered in my practice is that there seems to be a thought that once hepatic complications are identified, there is treatment for this, and in these patients, we can't reverse liver injury. Really, what we offer these patients is supportive care. These patients often can decompensate really quickly, and often these patients may require being transferred to the intensive care unit and it's not because there's any intervention that we're going to do. But I think it's very frustrating for nurses to see these severe liver injuries, that are life threatening, and not to be able to do anything about it.” TS 19:06 

In this enlightening episode, we dive into the fascinating connection between hormone pellets and mental health. Join us as we uncover how achieving hormonal balance can be a game-changer for your emotional well-being and mental resilience. In this episode, we are joined with Michelle Frank, MSN, APRN, CNP. Michelle is the CEO and founder of Esprit Health & Wellness, LLC. She is double-board-certified by the American Academy of Nurse Practitioners and the International Association for Physicians in Aesthetic Medicine. Her desire is to provide personalized solutions for her patients by listening to their concerns and developing treatment plans to help each patient reach his or her health targets. At Esprit, she takes a holistic approach to health promotion and is considered an expert in her field of bioidentical hormone replacement, weight loss, aesthetics, and wellness.  www.esprithealthclinic.com Disclaimer: The information, including but not limited to, text, graphics, images and other material contained on Qualgen's website and podcast are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.     

Around the world, cancer is on the rise in people under the age of 50 – an upward march that has been underway for decades. Even with stunning new advances in research, early detection, and treatment, many clinicians are worried about the prevalence of certain cancers, including breast, colon, kidney, liver, esophageal, and pancreatic cancers, in younger people. What's more, practitioners and public health experts are deeply concerned about missed screenings and delayed preventive care as a result of the COVID-19 pandemic and the impact that will have on persistent racially driven health disparities in cancer care, treatment, and survivorship for minority communities.  In this Moment of Awareness, Nurse Practitioner and researcher Timiya Nolan, PhD, APRN-CNP, ANP-BC describes her research as a “work of love” to young Black women, how representation allows research to move from academia to practice, and the power clinicians have in addressing disparities in care through partnership and collaboration with communities. To learn more, visit our website at www.seeyounowpodcast.com or contact us at hello@seeyounowpodcast.com.

In this latest episode of ASTCT Talks, Christina Ferraro, MSN, APRN-CNP, BMTCN, is joined by Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO, to discuss criteria used to determine who is eligible for CAR T cells, efforts between multi-disciplinary teams to select patients, ethical implications in patient selection and more. About Christina Ferraro Christina Ferraro completed her bachelor of science in nursing at The Ohio State University in 2001 and received a master of science in nursing and certification as a family nurse practitioner from Kent State University in 2016. She joined the Cleveland Clinic in 2003 as a registered nurse on the inpatient blood and marrow transplant unit and became an outpatient BMT nurse coordinator in 2006. Christina has been leading the Victor Fazio, MD BMT Cancer Survivorship Program at the Cleveland Clinic since 2016 and has experience in seeing patients with graft-versus-host disease and patients in long-term follow up, emphasizing patient empowerment, education and support. Christina has presented at numerous regional and national conferences including the Oncology Nursing Conference, Leukemia & Lymphoma Society, BMT Infonet, American Society of Transplantation and Cellular Therapy meetings, and Cleveland Clinic nursing grand rounds. Christina is an active author, presenter and educator on the topic of BMT and survivorship and participates in research focused on survivorship and post-transplant complications. About Beth Faiman Dr. Faiman is an exemplary leader in cancer nursing, conducting innovative research and integrating new medical knowledge into nursing practices. She is a founding member of the International Myeloma Foundation Nurse Leadership Board and co-developed nurse-led consult clinics to expedite diagnosis and management of thrombosis and plasma cell disorders. She is an adult nurse practitioner in the Department of Hematology/Oncology at the Cleveland Clinic. Dr. Faiman has influenced cancer care practice by presenting at international and US national conferences, serving as lecture chair, and receiving numerous awards and accolades. She is a Distinguished Fellow in the American Academy of Nursing and holds an appointment on the American Board of Internal Medicine Hematology maintenance of certification committee. She is editor of the Blood and Marrow Transplant certified Nurse (BMTCN) review manual and editor-in-chief of Journal of the Advanced Practitioner in Oncology (JADPRO).

Do you know the signs and symptoms of skin cancer? Laraine Kemery, MSN, APRN-CNP, R.N., AOCNP, shares tips for prevention, how to tell if a spot on your skin needs to be checked and what do if you have concerns.

Guest: Lisa Parks, MS, APRN-CNP, ANP-BC When considering prehabilitation for cancer patients about to undergo surgery, what factors should we keep in mind? Nurse Practitioner Lisa Parks from the Ohio State University Wexner Medical Center in Columbus, Ohio explores some of the key considerations involved in prehabilitation.

Guest: Lisa Parks, MS, APRN-CNP, ANP-BC To learn more about key considerations for prehabilitation, Nurse Practitioner Lisa Parks from the Ohio State University Wexner Medical Center in Columbus, Ohio recaps important factors to keep in mind for cancer patients undergoing surgery.

Guest: Lisa Parks, MS, APRN-CNP, ANP-BC For some cancer patients undergoing surgery, prehabilitation care could impact their outcomes. So what do nurses need to consider in their preoperative assessment? And what key players are part of the multidisciplinary healthcare team? Lisa Parks from the Ohio State University Wexner Medical Center in Columbus, Ohio explores key factors for cancer surgery.

COVID-19 added stress to infection preventionists resulting in anxiety, depression and burnout in their work lives that may have impacted their well-being. In this podcast episode, Dr. Melnyk speaks about infection preventionists' mental and physical health and lifestyle behaviors during the pandemic and their associations with perceived worksite wellness support, shift length, and race and/or ethnicity. With special guest: Bernadette Melnyk PhD, APRN-CNP, FAANP, FNAP, FAAN, Ohio State University Vice President for Health Promotion, University Chief Wellness Officer, Dean and Helene Fuld Health Trust Professor of Evidence-Based Practice, College of Nursing

What is it like to guide a professional association that serves more than 100,000 oncology nurses? ONS Directors-at-Large Deborah “Hutch” Allen, PhD, RN, CNS, FNP-BC, AOCNP®, Kris Mathey, MS, APRN-CNP, AOCNP®, and Jeanene “Gigi” Robison, MSN, APRN, AOCN®, reflect on how their varied nursing backgrounds and ONS experiences help the ONS Board to support a diverse membership during a conversation with ONS Executive Director Lori Brown. They also shared the professional and personal rewards that nurses can reap when getting involved with ONS at any level. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by December 23, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to oncology nursing leadership opportunities. Episode Notes Complete this evaluation for free NCPD. ONS Leadership Process ONS DEI Commitment Statement Oncology Nursing Podcast episodes: Episode 200: Meet the ONS Board of Directors: Houlihan, Ferguson, and Polovich Episode 213: Meet the ONS Board of Directors: Brant, Burger, and Knoop Episode 224: Meet the ONS Board of Directors: Nevidjon, Geddie, and Garner ONS Voice articles: Journeying Through Life With ONS Find Your Voice With ONS's Leadership Development Committee New Selection Process Supports Diversity on the ONS Board of Directors Nursing Leadership Has Space for Your and Your Goals Nursing Representation Is Critical in All Industries—Even Those Outside of Health Care ONS Leadership Learning Library ONS Strategic Plan Find all the ways to get involved with ONS at every level. Find an ONS chapter near you. To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode Deborah “Hutch” Allen: “The local, national, and making international connections has provided me with a lot of opportunities for networking and opening many new doors for other positions, including considering running for the Board of Directors member-at-large position for ONS this past year. Keep your mind open, be willing to listen, and accept new opportunities.” Timestamp (TS) 21:03 Jeanene “Gigi” Robison: “When we look at people in our lives and they are in leadership positions, whether that be locally or nationally, I think that they are good resource people for us when we have questions about pursuing that same direction.” TS 26:34 Gigi Robison: “Be open minded and think outside of the box. I believe it is crucial to listen to as many people as you can in order to have a diverse perspective.” TS 37:12 Hutch Allen: “I think it's harder to step back and say, ‘I'm not the expert,' but I am a lifelong learner. I love finding that ‘aha!' when I learn how to apply it to my life and into my practice, and I think that's the most important thing of becoming a board member and always saying to our members that I have to step out of myself, keep an open mind, listen, and provide feedback.” TS 38:33 Kris Mathey: “You really never know what you are going to gain from the people around you.” TS 40:47 Kris Mathey: “It takes only one chance to really get to where you're going. And you may fail along the way, but those are all learning experiences that are going to make you stronger.” TS 41:23 Kris Mathey: “My board involvement really fills my bucket and fills my heart and has really given me that extra—on those hard days at work when I just want to scream sometimes, the involvement in this has really made a difference and helps me keep going.” TS 45:38

“Our goal in surgical oncology is, of course, to treat the cancer for a cure, but to do it in a safe manner so the patient is able to recover and resume their normal living activities that they had before their surgery,” ONS member Lisa Parks, MS, APRN-CNP, ANP-BC, inpatient nurse practitioner of hepatobiliary surgery at the James Cancer Hospital and Solove Research Institute, Division of Surgical Oncology, at the Ohio State University Wexner Medical Center in Columbus, OH, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, during a discussion on prehabilitation and preoperative assessments for patients with cancer undergoing surgery, implications of and advancements in cancer surgery, and the interprofessional collaboration that takes place in this scenario. You can earn free NCPD contact hours after listening to this episode by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by August 19, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Complete this evaluation for free NCPD. Oncology Nursing Podcast episodes: Episode 58: The Power of Cancer Rehabilitation Episode 66: Updates in Surgical Oncology—ONS Congress Episode 185: Surgical Oncology: Where We've Come and Where We're Going Episode 212: When Cancer Care Gets Complex: Those Other Oncologic Emergencies ONS Voice article: The Power of Prehabilitation Clinical Journal of Oncology Nursing articles: Perioperative Care Implementation: Evidence-Based Practice for Patients With Pancreaticoduodenectomy Using the Enhanced Recovery After Surgery Guidelines Use of Robotics in Oncology Surgery Oncology Nursing Forum article: Cancer Prehabilitation Programs and Their Effects on Quality of Life ONS books: Surgical Oncology Nursing Gastrointestinal Cancer Care for Oncology Nurses Cancer Basics (second edition) ONS's Get Up, Get Moving Dana-Farber Cancer Institute article: How ‘Prehabilitation' Can Benefit Cancer Patients American Journal of Physical Medicine and Rehabilitation article: Cancer Prehabilitation: An Opportunity to Decrease Treatment-Related Morbidity, Increase Cancer Treatment Options, and Improve Physical and Psychological Health Outcomes Journal of Human Nutrition and Dietetics article: Nutritional Screening in a Cancer Prehabilitation Programme: A Cohort Study National Cancer Institute article: Surgery to Treat Cancer Enhanced Recovery After Surgery Society guidelines To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode “Prehabilitation for surgery is probably one of the most underutilized areas of the surgical process. The goal of prehabilitation is to initiate coordinated, preoperative, optimized strategies. During the patient's preoperative assessment by the oncology nurse in the clinic, as well as the provider, risk factors are identified that can be addressed for a better surgical outcome.” Timestamp (TS) 02:27 “Any solid tumor patient that is having an oncological surgery can benefit from prehabilitation. It really depends on their overall assessment preoperatively. . . . And certainly, any lengthy surgery that is going to require the patient to be under anesthesia for prolonged time, the patient would benefit from being optimized prior to a surgical procedure.” TS 07:43 “When a patient is initially seen by a surgical oncologist in a pre-op setting, all of these assessments are completed by the oncology nurse, as well as the advanced practice oncology nurse, for the patient. And in order for the patient to go through the surgical process, prehabilitation is started immediately after that initial visit. The patient will be brought back in and reassessed periodically while going through prehabilitation.” TS 09:03 “Our goal in surgical oncology is, of course, to treat the cancer for a cure, but to do it in a safe manner that the patient is able to recover and resume their normal activities that they've been living, that they had before their surgery.” TS 10:51 “I think [one] of the greatest challenges that I hear from nurses are family support. The family needs to understand the whole process of prehabilitation and the fact that the patient is not going to come to harm by waiting a couple weeks to optimize themselves to undergo a major cancer operation, and to make sure that they're providing transportation and assisting their family member if they need to go to outpatient physical therapy, occupational therapy, pulmonary rehab, things like that, that the provider may, based on assessment, refer these preoperative candidates for.” TS 12:18 “I think that people always think of surgery as being curative, but a lot of times, some of the procedures that we do are to sustain a quality of life for the patient at the end of their life.” TS 20:41 “Now, what I'm seeing is that the majority of the time, robotic surgery is utilized more often than an open surgery. Of course, any time there is uncontrolled bleeding, any time they're unable to really visualize the surgical field well, they may start out robotically, and then go to an open procedure, but certainly I'm seeing them starting the cases and scheduling them as robotic or robotic-assisted. . . . I just think that robotic-assisted surgery continues to really grow, and I don't think we've reached the full potential of what surgeons can do with the surgeries. There is a great learning curve for these surgical oncologists.” TS 28:10 “Surgical oncology nurses are trained in post-operative care, preoperative care, and for nurses that are in the OR, perioperative nursing, as well as oncology. They have to be competent, not only in surgical care, but in oncology care, too. . . . This specialty is very different than a medical oncology nurse, or a hematology nurse, who is mainly giving chemotherapies, CAR T's, immunotherapies. The surgical oncology nurse needs to understand what chemotherapies, treatments, radiation therapies, anything like that, that has been done with that patient, because that would certainly impact that patient's outcome, but also to understand the whole surgical process.” TS 31:28

One of our most requested topics…Cari sits down with Dr. Allison Carter to discuss the signs and symptoms of postpartum depression and how you can help identify them in yourself or someone you love. * This information is meant for educational and informational purposes only. You should not use this information to diagnose or treat any health problems without consulting your personal medical practitioner. Always seek the advice of your own medical practitioner about your specific health concerns and needs.

Join medical student Rilee Racine and Dr. Brian Stansfield, a neonatologist at the Children's Hospital of Georgia discuss Neonatal Opioid Withdrawal Syndrome, also known as NOWS.  After listening to this podcast, learners should be able to: Define neonatal opioid withdrawal syndrome Apply knowledge of signs and symptoms of NOWS to recognize these infants early Demonstrate general understanding of non-pharmacologic vs. pharmacologic management indications Recall the long term effects of NOWS and utilize this information to care for these infants long-term Educate families on clinical symptoms, management, and potential complications of NOWS Peer Review by Dr. Rebecca Yang and Dr. Amy Thompson Free CME Credit (requires sign-in): LINK COMING SOON Thank you for listening to this episode from the Department of Pediatrics at the Medical College of Georgia. If you have any comments, suggestions, or feedback- you can email us at mcgpediatricpodcast@augusta.edu. Remember that all content during this episode is intended for informational and educational purposes only. It should not be used as medical advice to diagnose or treat any particular patient. Clinical vignette cases presented are based on hypothetical patient scenarios. References: Anbalagan S, Mendez MD. Neonatal Abstinence Syndrome. 2020 Oct 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. PMID: 31855342. Armbruster, Debra PhD, APRN-CNP, NNP-BC, CPNP-PC, C-ELBW; Schwirian, Caitlyn PharmD; Mosier, Ashley MS, RN, CNL; Tam, Wai-Yin Mandy PharmD, BCPS, BCCCP; Prusakov, Pavel PharmD, BCPS, BCPPS Neonatal Abstinence Syndrome and Preterm Infants, Advances in Neonatal Care: March 05, 2021 - Volume Publish Ahead of Print - Issue - doi: 10.1097/ANC.0000000000000858 Finnegan LP. Neonatal abstinence syndrome: assessment and pharmacotherapy. In: Nelson N, editor. Current therapy in neonatal-perinatal medicine. 2 ed. Ontario: BC Decker; 1990. Jansson, Lauren M. MD. Neonatal abstinence syndrome. Uptodate. (2020). Johnson MR, Nash DR, Laird MR, Kiley RC, Martinez MA. Development and implementation of a pharmacist-managed, neonatal and pediatric, opioid-weaning protocol. J Pediatr Pharmacol Ther. 2014 Jul;19(3):165-73. doi: 10.5863/1551-6776-19.3.165. PMID: 25309146; PMCID: PMC4187529. Maguire, Denise J, PhD,R.N., C.N.L., Taylor, Susan, MSW,L.C.S.W.-C., C.M.A., Armstrong, K., PhD., Shaffer-Hudkins, E., Germain, A. M., M.D., Brooks, Sandra S,M.D., M.P.H., . . . Clark, L. (2016). Long-term outcomes of infants with neonatal abstinence syndrome: NN. Neonatal Network, 35(5), 277-286. doi:http://dx.doi.org/10.1891/0730-0832.35.5.277 Mangat, A. K., Schmölzer, G. M., & Kraft, W. K. (2019). Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS). Seminars in fetal & neonatal medicine, 24(2), 133–141. https://doi.org/10.1016/j.siny.2019.01.009 Merhar SL, Ounpraseuth S, Devlin LA, Poindexter BB, Young LW, Berkey SD, Crowley M, Czynski AJ, Kiefer AS, Whalen BL, Das A, Fuller JF, Higgins RD, Thombre V, Lester BM, Smith PB, Newman S, Sánchez PJ, Smith MC, Simon AE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT NEONATAL RESEARCH NETWORK AND THE NIH ENVIRONMENTAL INFLUENCES ON CHILD HEALTH OUTCOMES (ECHO) PROGRAM INSTITUTIONAL DEVELOPMENT AWARDS STATES PEDIATRIC CLINICAL TRIALS NETWORK. Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2021 Mar;147(3):e2020017830. doi: 10.1542/peds.2020-017830. PMID: 33632932; PMCID: PMC7919109. Protecting Our Infants Act of 2015, H.R, 1462, 114th Cong. (2015-2016).  Sarka Lisonkova, Lindsay L. Richter, Joseph Ting, Giulia M. Muraca, Qi Wen, Azar Mehrabadi, Sheona Mitchell-Foster, Eugenia Oviedo-Joekes and Janet Lyons. Pediatrics August 2019, 144 (2) e20183664; DOI: https://doi.org/10.1542/peds.2018-3664 Siegler R., Saffran J., Eisenberg N., Deloache, J., & Gershoff, E. (2017). How Children Develop (5th ed.). NY, NY, USA: Macmillan Learning.  Stephen W. Patrick, Wanda D. Barfield, Brenda B. Poindexter and COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION. Neonatal Abstinence Withdrawal Syndrome. Pediatrics November 2020, 146 (5) e2020029074; DOI: https://doi.org/10.1542/peds.2020-029074 Patrick SW, Barfield WD, Poindexter BB; COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION. Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2020 Nov;146(5):e2020029074. doi: 10.1542/peds.2020-029074. PMID: 33106341. Zimmermann, U., Rudin, C., Duò, A. et al. Treatment of opioid withdrawal in neonates with morphine, phenobarbital, or chlorpromazine: a randomized double-blind trial. Eur J Pediatr 179, 141–149 (2020). https://doi.org/10.1007/s00431-019-03486-6

Book Besties Season 1, Episode 8- My Sister's KeeperIn this episode of Book Besties, Molly and April will be talking about My Sister's Keeper by Jodi Picoult. This week we have our first guest, Katie Alexander, APRN-CNP(check out our social media to see her full bio). Join us this week as we get our minds blown by Katie, we hate on fictional characters and gush over Joan Cusack. Things talked about in this episode:My Sister's Keeper IMDB: https://www.imdb.com/title/tt1078588/?ref_=ext_shr_lnkLink's Katie mentions this episode: https://www.nccn.org/patients/guidelines/content/PDF/ped_all_patient.pdfhttps://www.alexslemonade.org/https://bethematch.org/patients-and-families/support-for-you-and-your-family/one-on-one-support/https://lls.org/support-resources/information-specialistsMeet Molly and April, they bonded over books and became Book Besties. So, what do you do when you find your book bestie? Start a podcast of course. Hang out with April and Molly as they talk about everything they love and hate about books.

Proceedings from the sixth in a series of 11 integrated webinars held in association with the 2021 ONS Annual Congress. Featuring perspectives from Drs Stephen M Ansell, Carla Casulo and John P Leonard on cases from the practices of Ms Jacklyn Gideon, Ms Robin Klebig and Ms Mollie Moran, including the following topics: Introduction (0:00) Case: A woman in her late 20s with Hodgkin lymphoma — Mollie Moran, APRN-CNP, AOCNP (10:39) Case: A man in his mid-70s with newly diagnosed follicular lymphoma — Robin Klebig, APRN, CNP, AOCNP (29:55) Case: A woman in her early 80s with relapsed diffuse large B-cell lymphoma (DLBCL) — Ms Klebig (52:58) Case: A woman in her mid-60s with relapsed DLBCL — Jacklyn Gideon, MSN, AGPCNP-BC (57:54) Case: A man in his early 70s with relapsed mantle cell lymphoma — Ms Gideon (1:15:26) NCPD information and select publications

Proceedings from from the tenth in a series of 11 integrated webinars held in association with the 2021 ONS Annual Congress. Featuring perspectives from Drs Brian T Hill, John M Pagel and Jennifer Woyach on cases from the practices of Ms Lesley Camille Ballance, Ms Kristen E Battiato and Ms Corinne Hoffman, including the following topics: Introduction (0:00) Overview of the Current Era of Chronic Lymphocytic Leukemia (CLL) Treatment (5:37) Up-Front Treatment of CLL with a BTK (Bruton Tyrosine Kinase) Inhibitor (10:24) Case: A woman in her mid-70s with CLL who receives first-line ibrutinib — Kristen E Battiato, AGNP-C (10:34) Case: A woman in her early 50s with previously untreated CLL who receives acalabrutinib — Lesley Camille Ballance, MSN, FNP-BC (34:17) Up-Front Treatment with Obinutuzumab/Venetoclax (53:31) Case: A man in his early 70s with CLL who desires time-limited therapy— Ms Battiato (53:55) Case: A man in his late 60s with CLL and malignant pleural effusions — Corinne Hoffman, MS, APRN-CNP, AOCNP (1:02:33) Case: A woman in her mid-40s with CLL who was initially observed off treatment — Ms Ballance (1:15:43) Future Directions in CLL Therapy (1:17:30) NCPD information and select publications

Dr. Bernadette Melnyk, PhD, APRN-CNP, FAANP, FNAP, FAAN, Dean, Helene Fuld Health Trust Professor of Evidence-based Practice and University Chief Wellness Officer at The Ohio State University College of Nursing discusses a new study by the college that found that critical care nurses nationwide reported high levels of stress, depressive symptoms and anxiety even before the COVID-19 pandemic began, and these factors correlated with an increase in self-reported medical errors. She talks about other findings in the study and resources for healthcare workers. The study was published in the "American Journal of Critical Care" (May 1, 2021). #COVID19 #Stress #Nurse

In this episode, Adrianne welcomes Nurse Practitioner, educator, mentor, blogger, cancer survivor and mom, Courtney Shihabuddin, DNP, APRN-CNP. She recounts her surreal experience being diagnosed with breast cancer just as COVID was causing the overwhelm and shutdown of healthcare facilities across the country in early 2020. She takes us through the timeline of her treatment, surgeries and complications very openly, candidly and with just enough humor to keep us from losing our composure.If all of that weren’t enough, they also discuss:-Care+Wear, the healthcare clothing company and its impact for recovering patients-The conflicts and benefits of being both a patient and a provider-How social media became a key piece of Coutrney’s treatment plan -How to (not) talk to someone who is panicking-Early detection and screening for breast cancer and potential challenges-How her personal life, work, and advocacy for other women intersected for CourtneyNaturally, Courtney and Adrianne talk a lot about breasts and how everyone should“Feel ‘Em on the First (of the Month)”Thank you to Courtney for discussing such personal subject matter on the show. You can find more of her content, including her blog, at:https://npcourtney.comYou can follow her on Instagram at @np.courtneyIf you are the proud owner and operator of a human body, please review the information below- find one that best fits you: Monthly Breast Exam VideosBreast self-exam: https://youtu.be/dQa_5uTRAz4Breast self- exam on larger breasts: https://youtu.be/HYUgMj0I-Aw Breast self-exam with implants: https://youtu.be/M5lDFwOlZtY Breast self-exam after mastectomy https://abcnews.go.com/Health/OnCallPlusScreeningAndDiagnosis/breast-exam-mastectomy/story?id=3642441 Breast self-exam on male: https://youtu.be/oH2w6ZCmkik -------------------------Like the show? Please support the future of the podcast by buying Adrianne a coffee!https://www.buymeacoffee.com/NUPodcastWant more nursing-related content? Find the podcast, blogs, videos, merch, and more at linktr.ee/nursinguncensoredpodcast ————————Recorded with Zoom and edited with Adobe Audition.————————Copyright-free music included in this episode found in the YouTube Audio Library:Care About You - Density & Time------------------ Nursing Uncensored participates in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com affiliated sites.

Health Matters is a weekly radio show sponsored by the Medicine Center Pharmacy on WHBC 1480 AM in Canton, Ohio. This episode pharmacists Brad White and Paul White discuss Stroke Awareness Month with Maria Griffin, APRN-CNP, coordinator for Cleveland Clinic Mercy Hospital’s Stroke Center. Topics will include risk factors, warning signs, preventive measures, treatment options and statistics related to stroke.   http://www.medshoprx.com  http://cantonmercy.org  

It's important to understand which vitamins the vast majority of Americans are deficient in so you can make the necessary adjustments to your diet. APRN, CNP Tiffany Hays at Neuropathy Treatment Clinic of Oklahoma is the special guest on episode 5 of NeuroPod. B Vitamins, D3, and probiotics should be incorporated in your diet daily. The symptoms of vitamin deficiencies can go unnoticed for extended time. The faster you educate yourself and develop a plan; the better quality of life you'll live. Understanding which vitamins you are deficient in, how you can incorporate them into your diet and what habits prevent the body from absorbing them will improve your health drastically. The vast majority of Americans are deficient in B vitamins, and D3. Animal products are the main source of b vitamins. If you are a vegan, it's important to supplement your b vitamins to ensure proper nutrition. Vitamin D3 can be consumed naturally simply by investing time outside and soaking up some sun. Many are dealing with a deficiency in vitamin D3 due to the pandemic. Most people are spending more time at the house than usual. Alcohol consumption is the leading cause of vitamin B deficiency. Just because your tolerance is great does not mean you must test it every weekend. Understand what is considered over-consumption of alcohol so your body gets the proper number of B vitamins it needs to stimulate your nerves. Learn more about vitamin deficiencies on episode 5 of NeuroPod with Tiffany Hays. If you have symptoms of pain, tingling or numbness in your hands and feet, we can help! Not only will we get you on a treatment plan to relieve your pain, we'll instill positive habits in your routine that will help you get back to living a pain-free life.Book a consultation by calling 918-921-8162 or at neuropathyok.com.

"Nurse Coaching is purposeful and strength based, and it is intended to connect with someone in a way that creates a really valuable partnership.  ​That partnership allows people to develop self-confidence and to take steps towards their wellness."  ~Alice TeallSilence and listening changes the dynamics of all relationships, making them more dynamic and authentic.It matters to teach healthcare professionals how to coach their patients and clients. It matters to the person using the coaching strategies, because they can feel effective, and it matters to the person they're coaching because instead of being told what to do, they can recognize they have strengths, and that they can change behavior.Health Coaching can happen in healthcare practitioner visits, and it doesn't take long to do!Coaching can happen in 5-minute sessions, or an hour session, or anywhere in between. It can happen in a hallway discussion, or an actual scheduled coaching session.  It can happen 1:1, or in groups.People need connection, and to know they have the ability within themselves to make a change that they want to make, or to be well in an area where they want to be well.Self-care does not need to be complicated. Self-care can mean doing something nurturing for one's self.A simple way to learn about yourself is to understand how silence impacts you and your relationships.Many people newly diagnosed with a disease process can experience grief. Nurse Coaching conversations can help patients connect with these feelings and move forward.Nurses are incredible health coaches, because they bring their knowledge, skill, and expertise to every coaching interaction.Why the acronym W.A.I.T. (why am I talking?) is so important to all humans!

In this episode we will be discussing research related to the Worldviews on Evidence Based Nursing article “The MINDBODYSTRONG Intervention for New Nurse Residents: 6-Month Effects on Mental Health Outcomes, Healthy Lifestyle Behaviors, and Job Satisfaction." Guests in this episode: Marlene Sampson, PhD, MSN-Ed, RN, Associate Director for Nursing Education, The Ohio State University Wexner Medical CenterBernadette Mazurek Melnyk, PhD, APRN-CNP, FAANP, FNAP, FAAN, Dean and Professor, The Ohio State University College of NursingJacqueline Hoying, PhD, RN, Assistant Professor of Clinical Practice, The Ohio State University College of Nursing

ONS member Lisa Parks, MS, APRN-CNP, ANP-BC, nurse practitioner in the division of surgical oncology at the Ohio State University James Cancer Hospital and Columbus ONS Chapter member, joins Chris Pirschel, ONS staff writer, to discuss what nurses need to know about robotic surgery in oncology, how to help their patients recover in post-op, and much more. Music Credit: "Fireflies and Stardust" Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 Episode Notes:  Check out these resources from today's episode: Complete this evaluation for free nursing continuing professional development. Innovations in Surgical Oncology: What Nurses Need to Know Under the Knife: Supporting Patients' Needs Throughout Surgical Oncology Care ONS Communities Surgical Oncology Nursing

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.